Acrivon Therapeutics
ACRV
#8032
Rank
โ‚น17.74 B
Marketcap
โ‚น569.86
Share price
0.30%
Change (1 day)
37.37%
Change (1 year)

Acrivon Therapeutics (ACRV) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น15.91 Billion

According to Acrivon Therapeutics's latest financial reports the company has โ‚น15.91 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Acrivon Therapeutics - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น10.57 B42.6%
2021-12-31โ‚น7.41 B6303.64%
2020-12-31โ‚น0.11 B